UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051347
Receipt number R000058163
Scientific Title Prediction for elevation value of platelet count in the blood and plasma concentration of fibrinogen following transfusion of platelet products and fresh frozen plasma during modifed ultrafiltration in cardiac surgeries for neonates and infants
Date of disclosure of the study information 2023/06/15
Last modified on 2024/02/13 21:48:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prediction for elevation value of platelet count in the blood and plasma concentration of fibrinogen following transfusion of platelet products and fresh frozen plasma during modifed ultrafiltration in cardiac surgeries for neonates and infants

Acronym

Elevation value of platelet count and fibrinogen concentration following transfusion of platelet products and fresh frozen plasma during modifed ultrafiltration in pediatric patients

Scientific Title

Prediction for elevation value of platelet count in the blood and plasma concentration of fibrinogen following transfusion of platelet products and fresh frozen plasma during modifed ultrafiltration in cardiac surgeries for neonates and infants

Scientific Title:Acronym

Elevation value of platelet count and fibrinogen concentration following transfusion of platelet products and fresh frozen plasma during modifed ultrafiltration in pediatric patients

Region

Japan


Condition

Condition

Congenital Heart Disease

Classification by specialty

Vascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Infants and neonates have smaller size of circulatory blood volume with respect to the cardiopulmonary bypass (CPB) circuits. Thus, marked hemodilution and decrease in platelet count and plasma concentration of fibrinogen occurs during cardiopulmonary bypass in cardiac surgeries for infants and neonates. Although transfusion of platelets and fresh frozen plasma (FFP) is required to normalize the platelet count and fibrinogen levels, the most pediatric patients cannot output enough urine volume with respect to the transfused volume. Therefore, transfusion of platelets and FFP following the completion of the CPB should be performed during modified ultrafiltration (MUF) period to eliminate excess water derived from the blood products.
The prediction formula for elevation values of platelet count and fibrinogen levels with transfusion of platelets and FFP during MUF is not yet established. We studied in the past postoperative values of platelet count and fibrinogen levels of infants and neonates who underwent transfusion of platelets and/or FFP during MUF. The study showed that the postoperative values have large variance and are lower than the predictive values: pre MUF values added predictive elevation values calculated from transfused volume of blood products, patient circulatory blood volume, CPB volume and MUF circuit volume. Our primary aim for this following study is to examine whether the platelet count and fibrinogen levels at cessation of transfusion of platelets and FFP during MUF, not at the time point on admission of postoperative care unit, are approximately equal to the prediction values calculated from our prediction formula or not. Our second aim for the study is to elucidate parameters and factors to cause dissociation variance of the actual measurement values from the predictive values.

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1) arterial blood gas, platelet count, and plasma concentration of fibrinogen at cessation of transfusion of plateles and fresh frozen plasma during MUF

Key secondary outcomes

2) fibrinogen concentration in the blood at cessation of transfusion of fresh frozen plasma during MUF
3) blood loss and the total amount of transfusion follwing cessation of the cardiopulmonary bypass
4) arterial blood gas, platelet count, and plasma concentration of fibrinogen on the time point of admission in the postoperative care unit


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Transfusion of platelets of 0 - 200 ml and fresh frozen plasma of 0 - 300 ml with elimination of excess water during modified ultrafiltration following cesssation of the cardiopulmonary bypass.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

1 years-old >

Gender

Male and Female

Key inclusion criteria

1) infants and neonates undergoing cardiac surgeries with cardiopulmonary bypass in our institution
And
2) written informed consent is obtained from a parent of each patient.

Key exclusion criteria

1) cases of written informed consent not obtained from the parent of the patient
Or
2) cases of modified ultrafiltration not performed following cessation of the cardiopoumonary bypass
Or
3) cases of modified ultrafiltration interrupted with second pump run

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Tatsuhiko
Middle name
Last name Masue

Organization

Gifu Prefectural Medical General Center

Division name

Department of Anesthesiology

Zip code

500-8717

Address

4-6-1 Noishiki Gifu city, Gifu prefecture, Japan

TEL

+81-58-246-1111

Email

tatsuhikomasue@yahoo.co.jp


Public contact

Name of contact person

1st name Tatsuhiko
Middle name
Last name Masue

Organization

Gifu Prefectural General Medical Center

Division name

Department of Anesthesiology

Zip code

500-8717

Address

4-6-1 Noishiki Gifu city Gifu prefecture, Japan

TEL

+81-58-246-1111

Homepage URL


Email

tatsuhikomasue@yahoo.co.jp


Sponsor or person

Institute

Kouki Fukuda
Department of Anesthesiology
Gifu Prefectural General Medical Center
4-6-1 Noishiki Gifu city Gifu prefecture 500-8717, Japan

Institute

Department

Personal name

Kouki Fukuda


Funding Source

Organization

Gifu Prefectural General Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Gifu Prefecture General Medical Center

Address

4-6-1 Noishiki Gifu city Gifu prefecture 500-8717, Japan

Tel

+81-58-246-1111

Email

tatsuhikomasue@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岐阜県総合医療センター(岐阜県)


Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 05 Month 08 Day

Date of IRB

2023 Year 06 Month 07 Day

Anticipated trial start date

2023 Year 06 Month 12 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 06 Month 15 Day

Last modified on

2024 Year 02 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058163


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name